ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 118 filers reported holding ANI PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 3.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,304,033 | +22.3% | 39,684 | +13.4% | 0.00% | +50.0% |
| Q2 2023 | $1,883,188 | +139395.4% | 34,984 | +2.9% | 0.00% | 0.0% |
| Q1 2023 | $1,350 | +6.2% | 33,985 | +7.5% | 0.00% | 0.0% |
| Q4 2022 | $1,271 | -99.9% | 31,603 | +3.0% | 0.00% | +100.0% |
| Q3 2022 | $986,000 | +10.0% | 30,677 | +1.6% | 0.00% | 0.0% |
| Q2 2022 | $896,000 | +23.1% | 30,195 | +16.5% | 0.00% | 0.0% |
| Q1 2022 | $728,000 | -36.4% | 25,916 | +4.4% | 0.00% | 0.0% |
| Q4 2021 | $1,144,000 | +11.7% | 24,820 | -20.4% | 0.00% | 0.0% |
| Q3 2021 | $1,024,000 | -15.2% | 31,189 | -9.5% | 0.00% | -50.0% |
| Q2 2021 | $1,207,000 | -4.1% | 34,446 | -1.1% | 0.00% | 0.0% |
| Q1 2021 | $1,259,000 | +28.7% | 34,824 | +3.4% | 0.00% | +100.0% |
| Q4 2020 | $978,000 | +13.9% | 33,674 | +10.6% | 0.00% | 0.0% |
| Q3 2020 | $859,000 | -16.4% | 30,435 | -4.3% | 0.00% | -50.0% |
| Q2 2020 | $1,028,000 | -20.4% | 31,798 | +0.3% | 0.00% | -33.3% |
| Q1 2020 | $1,291,000 | -32.4% | 31,700 | +2.4% | 0.00% | 0.0% |
| Q4 2019 | $1,909,000 | -8.8% | 30,954 | +7.7% | 0.00% | -25.0% |
| Q3 2019 | $2,094,000 | -3.9% | 28,737 | +8.4% | 0.00% | 0.0% |
| Q2 2019 | $2,180,000 | +28.3% | 26,516 | +10.1% | 0.00% | +33.3% |
| Q1 2019 | $1,699,000 | +55.0% | 24,080 | -1.1% | 0.00% | +50.0% |
| Q4 2018 | $1,096,000 | -6.3% | 24,339 | +17.6% | 0.00% | 0.0% |
| Q3 2018 | $1,170,000 | -19.9% | 20,697 | -5.3% | 0.00% | -33.3% |
| Q2 2018 | $1,461,000 | +22.6% | 21,866 | +6.8% | 0.00% | +50.0% |
| Q1 2018 | $1,192,000 | -6.5% | 20,467 | +3.4% | 0.00% | -33.3% |
| Q4 2017 | $1,275,000 | +43.1% | 19,789 | +16.5% | 0.00% | +50.0% |
| Q3 2017 | $891,000 | +19.1% | 16,982 | +6.2% | 0.00% | 0.0% |
| Q2 2017 | $748,000 | -6.0% | 15,992 | -0.5% | 0.00% | 0.0% |
| Q1 2017 | $796,000 | +6.3% | 16,073 | +30.2% | 0.00% | 0.0% |
| Q4 2016 | $749,000 | +2.0% | 12,348 | +11.6% | 0.00% | 0.0% |
| Q3 2016 | $734,000 | +30.4% | 11,060 | +9.7% | 0.00% | 0.0% |
| Q2 2016 | $563,000 | +69.1% | 10,080 | +2.0% | 0.00% | +100.0% |
| Q1 2016 | $333,000 | -24.7% | 9,886 | +1.0% | 0.00% | 0.0% |
| Q4 2015 | $442,000 | +22.8% | 9,786 | +7.3% | 0.00% | 0.0% |
| Q3 2015 | $360,000 | -34.9% | 9,116 | +2.2% | 0.00% | -50.0% |
| Q2 2015 | $553,000 | -0.7% | 8,920 | +0.1% | 0.00% | 0.0% |
| Q1 2015 | $557,000 | +47.4% | 8,910 | +32.8% | 0.00% | +100.0% |
| Q4 2014 | $378,000 | – | 6,710 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 367,754 | $10,911,000 | 4.08% |
| AIGH Capital Management LLC | 244,500 | $7,254,000 | 1.91% |
| Parkman Healthcare Partners LLC | 108,559 | $3,221,000 | 1.19% |
| Worth Venture Partners, LLC | 60,831 | $1,927,000 | 1.13% |
| Global Alpha Capital Management Ltd. | 323,731 | $9,605,000 | 1.04% |
| Mesirow Financial Investment Management, Inc. | 6,892 | $204,000 | 0.99% |
| MARATHON CAPITAL MANAGEMENT | 74,460 | $2,209,000 | 0.71% |
| EMERALD ADVISERS, LLC | 455,880 | $13,526,000 | 0.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 356,865 | $10,588,000 | 0.61% |
| Jackson Creek Investment Advisors LLC | 32,698 | $1,120,000 | 0.45% |